CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net loss	$ (674,451)	$ (500,950)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of patents and proprietary technology		15,958
Amortization of discount on note payable	800	106,432
Depreciation	1,679	1,679
Gain on settlement of debt		(90,325)
Gain on forgiveness of debt		(57,320)
Gain (loss) on change in fair value of derivative liabilities		440,367
Changes in operating assets and liabilities:
Accounts receivable	(41,692)	(23,690)
Prepaid expenses and other assets	(732)	(4,500)
Accounts payable	52,482	(107,498)
Accounts payable - related parties	3,003	19,000
Accrued liabilities	305,733	288,748
Net Cash Provided by (Used) in Operating Activities	(353,178)	87,901
Cash Flows from Financing Activities:
Proceeds from borrowings under note payable	109,500
Proceeds from bank overdrafts	63,674
Proceeds from borrowings under convertible note payable	10,000	100,000
Net Cash Provided by Financing Activities	183,174	100,000
Net Change in Cash and Cash Equivalents	(170,004)	187,901
Cash and Cash Equivalents at Beginning of Period	170,004	17,798
Cash and Cash Equivalents at End of Period		205,699
Supplemental Cash Flow Information:
Cash paid for income taxes
Cash paid for interest
Supplemental Disclosure on Noncash Investing and Financing Activities
Recognition of discounts on convertible notes payable	2,000	86,327
Conversion of note payable and accrued interest to common stock		410,574
Conversion of due to related party to convertible notes		39,000
Gain on settlement of debt		90,325
Gain on forgiveness of debt		$ 57,320